Selenium and the thyroid: A close-knit connection

Introduction: In areas with severe selenium deficiency higher incidence of thyroiditis has been reported due to a decreased activity of selenium-dependent glutathione peroxidase enzyme within thyroid cells. Aims and Objective: To study the effect of selenium supplementation in patients with autoimmu...

Full description

Bibliographic Details
Main Authors: Ashok K Bhuyan, Dipti Sarma, Uma K Saikia
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2012-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2012;volume=16;issue=8;spage=354;epage=355;aulast=Bhuyan
id doaj-dbff2ae3edf0465da2c9aeea0eb16129
record_format Article
spelling doaj-dbff2ae3edf0465da2c9aeea0eb161292020-11-24T22:46:39ZengWolters Kluwer Medknow PublicationsIndian Journal of Endocrinology and Metabolism2230-82102230-95002012-01-0116835435510.4103/2230-8210.104090Selenium and the thyroid: A close-knit connectionAshok K BhuyanDipti SarmaUma K SaikiaIntroduction: In areas with severe selenium deficiency higher incidence of thyroiditis has been reported due to a decreased activity of selenium-dependent glutathione peroxidase enzyme within thyroid cells. Aims and Objective: To study the effect of selenium supplementation in patients with autoimmune thyroid disease. Materials and Methods: This is a blinded placebo-controlled prospective study done in 60 patients with autoimmune thyroid disease (as defined by an anti-thyroid peroxidase antibody (TPOAb) level more than 150 IU/ml) irrespective of the baseline thyroid status. Patients with overt hyperthyroidism who are on antithyroid drugs, patients on any other medication, which may alter the immunity status of the patients, and pregnant patients were excluded from the study. Patients were randomized into two age and TPOAb-matched groups; 30 patients received 200 μg of sodium selenite/day, orally, for 3 months, and 30 patients received placebo. All hypothyroid patients were given l-thyroxine replacement. Results: Of 30 patients in the selenium treated group, 6 patients were overtly hypothyroid, 15 were subclinical hypothyroid, 6 were euthyroid, and 3 were subclinical hyperthyroid. The mean TPOAb concentration decreased significantly by 49.5% (P < 0.013) in the selenium treated group versus 10.1% (P < 0.95) in the placebo-treated group. Conclusion: Selenium substitution has a significant impact on inflammatory activity in thyroid-specific autoimmune disease. It would be of interest to determine whether early treatment with selenium in patients with newly developed autoimmune thyroiditis may delay or even prevent the natural course of these diseases.http://www.ijem.in/article.asp?issn=2230-8210;year=2012;volume=16;issue=8;spage=354;epage=355;aulast=BhuyanSeleniumthyroid
collection DOAJ
language English
format Article
sources DOAJ
author Ashok K Bhuyan
Dipti Sarma
Uma K Saikia
spellingShingle Ashok K Bhuyan
Dipti Sarma
Uma K Saikia
Selenium and the thyroid: A close-knit connection
Indian Journal of Endocrinology and Metabolism
Selenium
thyroid
author_facet Ashok K Bhuyan
Dipti Sarma
Uma K Saikia
author_sort Ashok K Bhuyan
title Selenium and the thyroid: A close-knit connection
title_short Selenium and the thyroid: A close-knit connection
title_full Selenium and the thyroid: A close-knit connection
title_fullStr Selenium and the thyroid: A close-knit connection
title_full_unstemmed Selenium and the thyroid: A close-knit connection
title_sort selenium and the thyroid: a close-knit connection
publisher Wolters Kluwer Medknow Publications
series Indian Journal of Endocrinology and Metabolism
issn 2230-8210
2230-9500
publishDate 2012-01-01
description Introduction: In areas with severe selenium deficiency higher incidence of thyroiditis has been reported due to a decreased activity of selenium-dependent glutathione peroxidase enzyme within thyroid cells. Aims and Objective: To study the effect of selenium supplementation in patients with autoimmune thyroid disease. Materials and Methods: This is a blinded placebo-controlled prospective study done in 60 patients with autoimmune thyroid disease (as defined by an anti-thyroid peroxidase antibody (TPOAb) level more than 150 IU/ml) irrespective of the baseline thyroid status. Patients with overt hyperthyroidism who are on antithyroid drugs, patients on any other medication, which may alter the immunity status of the patients, and pregnant patients were excluded from the study. Patients were randomized into two age and TPOAb-matched groups; 30 patients received 200 μg of sodium selenite/day, orally, for 3 months, and 30 patients received placebo. All hypothyroid patients were given l-thyroxine replacement. Results: Of 30 patients in the selenium treated group, 6 patients were overtly hypothyroid, 15 were subclinical hypothyroid, 6 were euthyroid, and 3 were subclinical hyperthyroid. The mean TPOAb concentration decreased significantly by 49.5% (P < 0.013) in the selenium treated group versus 10.1% (P < 0.95) in the placebo-treated group. Conclusion: Selenium substitution has a significant impact on inflammatory activity in thyroid-specific autoimmune disease. It would be of interest to determine whether early treatment with selenium in patients with newly developed autoimmune thyroiditis may delay or even prevent the natural course of these diseases.
topic Selenium
thyroid
url http://www.ijem.in/article.asp?issn=2230-8210;year=2012;volume=16;issue=8;spage=354;epage=355;aulast=Bhuyan
work_keys_str_mv AT ashokkbhuyan seleniumandthethyroidacloseknitconnection
AT diptisarma seleniumandthethyroidacloseknitconnection
AT umaksaikia seleniumandthethyroidacloseknitconnection
_version_ 1725684409213911040